Medicenna Therapeutics Co... (MDNA)

AI Score

Unlock

0.16

0.00 (1.91%)

At close: Jan 16, 2025, 9:00 PM

Medicenna Therapeutics Income Statement

Financials in CAD. Fiscal year is April - March.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-6.81M	-5.71M	-1.7M	-8.36M	-7.1M	-4.47M	-3.04M	-4.97M	-8.27M	-6.02M	-5.58M	-5.16M	-3.85M	-2.59M	-2.63M	-2.41M	-1.87M	-1.29M	-1.1M	-1.7M	-880.69K	-1.06M	-1.3M	-2.17M	-1.68M	-2.23M	-4.35M	-2.21M	-6.13K	-10.66K	-8.83K	-565.78	-157.11K	-14.76K
Interest Income	342K	346K	382K	340K	162K	30K	9K	16K	21K	23K	27K	46K	95K	145.86K	6.73K	n/a	n/a	n/a	n/a	1.00	n/a	92.00	n/a	376.00	443.00	2.3K	20.82K	6.43K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3.72M	-2.86M	-3.86M	-1.14M	-896K	-4.16M	-3.21M	-4.81M	-8.18M	-6.39M	-5.81M	-5.34M	-3.79M	-2.35M	-2.69M	-2.39M	-1.9M	-1.29M	-1.05M	-1.72M	-897.66K	-1.04M	-1.31M	-2.18M	-1.72M	-2.26M	-4.36M	-2.18M	-16.91K	-10.66K	-15.55K	-566.33	-157.11K	-14.76K
Net Income	-3.72M	-2.86M	-6.01M	-1.48M	-1.06M	-4.16M	-3.21M	-4.81M	-8.18M	-6.39M	-5.81M	-5.34M	-3.79M	-2.35M	-2.69M	-2.39M	-1.9M	-1.29M	-1.05M	-1.72M	-897.66K	-1.04M	-1.31M	-2.18M	-1.72M	-2.26M	-4.36M	-2.18M	-16.91K	-10.66K	-15.55K	-566.33	-157.11K	-14.76K
Selling & General & Admin	2.3M	1.65M	1.38M	1.97M	1.72M	1.92M	1.93M	1.98M	1.95M	1.86M	1.97M	2.09M	1.69M	722.01K	525.15K	740.55K	641.31K	585.67K	529.37K	563K	510.93K	561.07K	585.3K	1M	797.03K	612.32K	2.48M	619.98K	6.13K	10.66K	8.83K	38.20	157.11K	14.76K
Research & Development	3.13M	2.81M	1.59M	2.94M	2.36M	2.41M	1.19M	2.91M	6.27M	4.35M	3.7M	3.18M	2.18M	1.81M	2.14M	1.66M	1.25M	828.44K	661.31K	1.28M	445.81K	634.97K	864K	1.35M	1.07M	1.8M	2.04M	1.6M	n/a	n/a	n/a	618.36	n/a	n/a
Other Expenses	n/a	n/a	1K	2K	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.78K	n/a	-6.73K	n/a	n/a	n/a
Operating Expenses	5.44M	4.46M	2.97M	4.92M	4.08M	4.33M	3.13M	4.9M	8.23M	6.22M	5.71M	5.27M	3.87M	2.55M	2.66M	2.4M	1.89M	1.29M	1.08M	1.71M	889.18K	1.05M	1.3M	2.18M	1.7M	2.24M	4.37M	2.22M	6.13K	10.66K	8.83K	566.08	157.11K	14.76K
Interest Expense	n/a	n/a	2.15M	340K	162K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	29.00	n/a	n/a	n/a	0.25	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.44M	4.46M	2.97M	4.92M	4.08M	4.33M	3.13M	4.9M	8.23M	6.22M	5.71M	5.27M	3.87M	2.55M	2.66M	2.4M	1.89M	1.29M	1.08M	1.71M	889.18K	1.05M	1.3M	2.18M	1.7M	2.24M	4.37M	2.22M	6.13K	10.66K	8.83K	-566.08	157.11K	14.76K
Income Tax Expense	n/a	-1.6M	2.15M	340K	162K	-175.01K	79K	-90K	-55K	170K	104K	65K	-81K	-193.53K	23.97K	-11.77K	15.42K	4.65K	-26.39K	9.97K	8.48K	-11.31K	6.05K	5.31K	16.47K	12.79K	n/a	29.00	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	69.64M	69.64M	69.55M	69.64M	63.55M	56.13M	55.55M	54M	53.74M	53.55M	52.21M	49.25M	48.85M	48.34M	36.98M	33.19M	28.8M	28.62M	28.53M	25.01M	24.58M	24.58M	24.47M	24.34M	24.34M	24.31M	24.31M	1.16M	357.14K	357.14K	357.14K	16.25K	332.68K	1.07M
Shares Outstanding (Diluted)	69.64M	69.64M	69.55M	69.64M	63.55M	56.13M	55.55M	54M	53.74M	53.55M	52.21M	49.25M	48.85M	48.34M	36.98M	33.19M	28.8M	28.62M	28.53M	25.01M	24.58M	24.58M	24.47M	24.34M	24.34M	24.31M	24.31M	1.16M	357.14K	357.14K	357.14K	16.25K	332.68K	1.07M
EPS (Basic)	-0.05	-0.04	-0.09	-0.02	-0.02	-0.07	-0.06	-0.09	-0.15	-0.12	-0.11	-0.11	-0.08	-0.05	-0.07	-0.07	-0.07	-0.05	-0.04	-0.07	-0.04	-0.04	-0.05	-0.09	-0.07	-0.09	-0.18	-1.88	-0.05	-0.03	-0.04	-0.03	-0.47	-0.01
EPS (Diluted)	-0.05	-0.04	-0.09	-0.02	-0.02	-0.07	-0.06	-0.09	-0.15	-0.12	-0.11	-0.11	-0.08	-0.05	-0.07	-0.07	-0.07	-0.05	-0.04	-0.07	-0.04	-0.04	-0.05	-0.09	-0.07	-0.09	-0.18	-1.88	-0.05	-0.03	-0.04	-0.03	-0.47	-0.01
EBITDA	-6.81M	-5.71M	-1.7M	-4.92M	-4.73M	-4.32M	-3.12M	-4.96M	-8.26M	-6.01M	-5.57M	-5.15M	-3.84M	-2.58M	-2.63M	-2.41M	-1.87M	-1.28M	-1.07M	-1.7M	-878.98K	-1.06M	-1.3M	-2.17M	-1.68M	-2.22M	-4.35M	-2.21M	-6.13K	-10.66K	-8.83K	-565.61K	-157.11K	-14.76K
EBIT	n/a	n/a	-1.7M	-1.14M	-1.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.19M	n/a	n/a	n/a	-565.79K	n/a	n/a
Depreciation & Amortization	1K	1K	1K	1K	2K	41.58K	8K	10K	10K	10K	11K	10K	8.93K	10.07K	4.18K	1.24K	1.24K	1.24K	1.7K	1.71K	1.7K	1.71K	1.71K	1.71K	1.7K	4.59K	1.24K	2.78K	n/a	n/a	n/a	0.18	n/a	n/a